Amgen Fights IRS Over $10.7 Billion Tax Bill

Amgen is fighting a $10.7 billion tax bill from the IRS, which says the biotech improperly shifted nearly $24 billion in profits to a Puerto Rico subsidiary to reduce its tax burden.